M42, 10X Health, REVIV Global team up to launch 10XREVIV for precision health

A new chapter in precision health is unfolding. M42, the Abu Dhabi-based powerhouse in tech-driven healthcare, has teamed up with US firm 10X Health and UK's REVIV Global to launch 10XREVIV — a venture that promises to rewrite how we think about nutrition, longevity, and personal wellness. It's not just another health partnership. It's a bet on a future where science and AI work hand-in-hand to optimize the human body.

As M42's Albarah El Khani put it, "We are committed to redefining how healthcare is delivered by integrating AI, data, and life sciences to unlock human potential."

How does it work?

At the center of this alliance sits the 10X Precision Nutrition System, a platform more than a decade in the making.

• It crunches up to 20 million genetic variations with nearly perfect accuracy.
• It merges DNA, blood biomarkers, and lifestyle data to create a personalized health blueprint.
• It delivers this as a 400+ page digital report, mapping everything from nutrient absorption to cardiovascular health.

Once the data is in, 10XREVIV translates it into precision-based interventions:

• 10X Precision Supplements: micro-bead formulations with up to 22 micronutrients designed for maximum compatibility.
• 10X Precision Weight Management Solutions: individualized carbohydrate and fat modulators that sync with one's metabolism.
• Precision IV Therapy: customized, genetically informed infusions available through certified clinics.

This isn't one-size-fits-all wellness. It's a science-backed playbook written in your DNA.

Why does it matter?

The move signals a major leap from reactive medicine to preventive and predictive care. Instead of waiting for illness, this system aims to catch and correct imbalances before they spiral into disease.
Brandon Dawson, CEO of 10X Health, called it "a new global benchmark for human optimization — where science, technology, and clinical application converge."

The collaboration doesn't stop at products. The partners plan to open a Precision Longevity flagship clinic, run a clinical trial on IV nutrition and Type 2 Diabetes, and launch a Precision Nutrition training curriculum for medical professionals. That means the science behind it won't stay confined to elite labs but will ripple through clinics and hospitals across the region.

The context

The timing couldn't be more apt. Across the Middle East, healthcare is shifting gears — from treatment to transformation. M42 has been at the forefront of that change, using AI and genomics to move medicine into the data era. REVIV, already a leader in IV therapy, brings the clinical finesse. 10X Health adds the algorithmic muscle and biotech expertise.

As Sarah Lomas of REVIV Global said, "This alliance elevates our vision by combining cutting-edge genetics, AI-driven nutrition and world-class clinical delivery." Together, these players are blending hard science with human aspiration — a fusion that could well define the next frontier of health.

Would you like me to make it slightly more journalistic (with a magazine-style flair) or keep it in this clear authoritative tone?